THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Suitors take Guidant fight to The Street

Boston Scientific, J&J lobby analysts as deadline nears

By Stephen Heuser
Globe Staff / January 20, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

With the clock ticking down for Johnson & Johnson to answer Boston Scientific's $27 billion bid for Guidant Corp. , the two rivals are trying to torpedo each other's bids with Wall Street analysts and major stockholders. (Full article: 733 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass